Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor
申请人:Abbott Laboratories
公开号:US05190922A1
公开(公告)日:1993-03-02
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.
US5190922A
申请人:——
公开号:US5190922A
公开(公告)日:1993-03-02
[EN] TERMINALLY MODIFIED TRI-, TETRA- AND PENTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS
申请人:ABBOTT LABORATORIES
公开号:WO1992021361A1
公开(公告)日:1992-12-10
(EN) Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.(FR) Des composés d'oligopeptides ou des composés d'analogues d'oligopeptides de la formule A-B-D-E-G-J-L constituent des ligands du récepteur d'anaphylatoxine et sont utiles dans le traitement d'états pathologiques inflammatoires. L'invention concerne également des compositions de ligands de récepteur d'anaphylatoxine ainsi qu'un procédé modulant l'activité de l'anaphylatoxine.
Preparation of Some Primary and Secondary β-Cyclohexylalkylamines<sup>1</sup>
作者:Bernard L. Zenitz、Elizabeth B. Macks、Maurice L. Moore